BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10586541)

  • 21. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
    Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
    J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of urinary excretion of technetium-99m-MAG3.
    Russell CD; Dubovsky EV; Taylor AT
    J Nucl Med; 1998 Jul; 39(7):1257-9. PubMed ID: 9669405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective renal plasma flow calculated from a single blood sample following Technetium-99m mercaptoacetyltriglycine renal scan can predict delayed graft function in renal transplantation.
    Freedland SJ; Mishkin F; Shoskes DA
    Tech Urol; 2001 Dec; 7(4):281-4. PubMed ID: 11763488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renal parenchyma evaluation: MAG3 vs. DMSA.
    Smokvina A; Grbac-Ivanković S; Girotto N; Dezulović MS; Saina G; Barković MM
    Coll Antropol; 2005 Dec; 29(2):649-54. PubMed ID: 16417177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tc-99m mercaptoacetyltriglycine clearance: comparison of camera-assisted methods.
    Bocher M; Shrem Y; Tappiser A; Klein M; Schechter D; Taylor A; Chisin R
    Clin Nucl Med; 2001 Sep; 26(9):745-50. PubMed ID: 11507290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest.
    Inoue Y; Yoshikawa K; Yoshioka N; Watanabe T; Saegusa S; Kaneko Y; Yokoyama I; Ohtomo K
    J Nucl Med; 2000 Dec; 41(12):1947-54. PubMed ID: 11138677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative indicators of renal function in scintigraphy with mercaptoacetyl-triglycine in patients with transplanted kidneys (99m TC MAG3 in the quantitative evaluation of the transplanted kidney)].
    Beatović S; Krajnović-Jaksić E; Blagojević-Lazić R; Djukanović Lj; Han R
    Srp Arh Celok Lek; 1996; 124 Suppl 1():194-6. PubMed ID: 9102904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
    Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
    Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (99m)Tc-mercaptoacetyl triglycine renography to monitor renal transplant function among kidneys from donors after cardiac death.
    Majima T; Hattori R; Funahashi Y; Komatsu T; Kato M; Yamada S; Kamihira O; Goto M
    Transplant Proc; 2012 Jan; 44(1):49-53. PubMed ID: 22310576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney function after nephrectomy for renal cell carcinoma.
    Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
    Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A; Eshima D; Christian PE; Milton W
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of renal allograft dysfunction employing dynamic SPECT with 99mTc-MAG3 and graph plot analysis].
    Akahira H
    Kaku Igaku; 1996 Nov; 33(11):1227-37. PubMed ID: 8986062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 99Tcm-MAG3: a sensitive indicator for evaluating perfusion and rejection of renal transplants.
    Oriuchi N; Miyamoto K; Hoshino K; Imai J; Takahashi Y; Sakai S; Shimada A; Endo K
    Nucl Med Commun; 1997 May; 18(5):400-4. PubMed ID: 9194080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
    Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
    J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tc-99m MAG3 renal transplant imaging of scrotal urinoma.
    Banzo I; Gomez-Barquín R; Quirce R; Blanco I; Montero A; Carril JM
    Clin Nucl Med; 1997 Jun; 22(6):401-2. PubMed ID: 9193816
    [No Abstract]   [Full Text] [Related]  

  • 36. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method.
    Werner E; Blasl C; Reiners C
    J Nucl Med; 1998 Jun; 39(6):1066-9. PubMed ID: 9627345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraperitoneal urine leak in a patient with a renal transplant on Tc-99m MAG3 imaging.
    Goodear M; Barratt L; Wycherley A
    Clin Nucl Med; 1998 Nov; 23(11):789-90. PubMed ID: 9814579
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple objective parameter for perfusion study of renal transplant.
    Koizumi K; Kakiuchi H; Saguchi T; Inoue S; Fuse S; Kawakami E; Yamazaki A; Kozaki K; Nagao T
    Ann Nucl Med; 2001 Feb; 15(1):27-32. PubMed ID: 11355778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal activity on Tc-99m MAG3 scintigraphy in a patient after renal transplant may interfere with interpretation.
    Barnes S; Shih WJ; Saylor M
    Clin Nucl Med; 2000 Aug; 25(8):643-4. PubMed ID: 10944031
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.